56 related articles for article (PubMed ID: 15754961)
1. [Diabetes mellitus in elderly: geroprotective and antidiabetic properties of delta-sleep induced peptide].
Odin VI; Belikova TV; Pushkova ES; Barr NA
Adv Gerontol; 2004; 15():101-14. PubMed ID: 15754961
[TBL] [Abstract][Full Text] [Related]
2. [Effect of delta-sleep inducing peptide preparation Deltaran on longevity, physiological functions, and carcinogenesis in mice].
Voĭtenkov VB; Popovich IG; Zabezhinskiĭ MA; Iurova MA; Piskunova TA; Mikhaleva II
Adv Gerontol; 2009; 22(4):646-54. PubMed ID: 20405733
[TBL] [Abstract][Full Text] [Related]
3. [Delta-sleep inducing peptide and the drug deltaran: possible approaches to antistress protection].
Koplik EV; Umriukhin PE; Konorova IL; Terekhina OL; Mikhaleva II; Gannushkina IV; Sudakov KV
Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(12):50-4. PubMed ID: 18427460
[TBL] [Abstract][Full Text] [Related]
4. Troglitazone, an insulin action enhancer, improves glycaemic control and insulin sensitivity in elderly type 2 diabetic patients.
Kumar S; Prange A; Schulze J; Lettis S; Barnett AH
Diabet Med; 1998 Sep; 15(9):772-9. PubMed ID: 9737807
[TBL] [Abstract][Full Text] [Related]
5. [Mechanism of delta-sleep inducing peptide geroprotective activity].
Bondarenko TI; Maĭboroda EA; Mikhaleva II; Prudchenko IA
Adv Gerontol; 2011; 24(1):80-92. PubMed ID: 21809625
[TBL] [Abstract][Full Text] [Related]
6. Added benfluorex in obese insulin-requiring type 2 diabetes.
Leutenegger M; Bauduceau B; Brun JM; Guillon-Metz F; Martin C; Nicolino-Peltier C; Richard JL; Vannereau D
Diabetes Metab; 1998 Feb; 24(1):55-61. PubMed ID: 9534010
[TBL] [Abstract][Full Text] [Related]
7. Effect of delta-sleep inducing peptide-containing preparation Deltaran on biomarkers of aging, life span and spontaneous tumor incidence in female SHR mice.
Popovich IG; Voitenkov BO; Anisimov VN; Ivanov VT; Mikhaleva II; Zabezhinski MA; Alimova IN; Baturin DA; Zavarzina NY; Rosenfeld SV; Semenchenko AV; Yashin AI
Mech Ageing Dev; 2003 Jun; 124(6):721-31. PubMed ID: 12782416
[TBL] [Abstract][Full Text] [Related]
8. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
Fabian W; Majkowska L; Stefański A; Moleda P
Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
[TBL] [Abstract][Full Text] [Related]
9. Antiepileptic activity of delta sleep-inducing peptide and its analogue in metaphit-provoked seizures in rats.
Stanojlović OP; Zivanović DP; Mirković SD; Mikhaleva II
Seizure; 2005 Jun; 14(4):240-7. PubMed ID: 15911358
[TBL] [Abstract][Full Text] [Related]
10. [Using deltalicin for the treatment of patients with diabetic retinopathy].
Kresiun NV; Godlevskiĭ LS
Eksp Klin Farmakol; 2014; 77(12):22-5. PubMed ID: 25739189
[TBL] [Abstract][Full Text] [Related]
11. Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients.
Miyazaki Y; Mahankali A; Wajcberg E; Bajaj M; Mandarino LJ; DeFronzo RA
J Clin Endocrinol Metab; 2004 Sep; 89(9):4312-9. PubMed ID: 15356026
[TBL] [Abstract][Full Text] [Related]
12. Promising new approaches.
Reasner CA
Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
[TBL] [Abstract][Full Text] [Related]
13. Study of delta sleep-inducing peptide efficacy in improving sleep on short-term administration to chronic insomniacs.
Monti JM; Debellis J; Alterwain P; Pellejero T; Monti D
Int J Clin Pharmacol Res; 1987; 7(2):105-10. PubMed ID: 3583493
[TBL] [Abstract][Full Text] [Related]
14. Rosiglitazone combined with insulin preserves islet beta cell function in adult-onset latent autoimmune diabetes (LADA).
Zhou Z; Li X; Huang G; Peng J; Yang L; Yan X; Wang J
Diabetes Metab Res Rev; 2005; 21(2):203-8. PubMed ID: 15386806
[TBL] [Abstract][Full Text] [Related]
15. [Nutritional and metabolic status and dietetic evaluation in institutionalized elderly patients with non-insulin-dependent diabetes mellitus].
Casimiro C; García de Lorenzo A; Usán L;
Nutr Hosp; 2001; 16(3):104-11. PubMed ID: 11475679
[TBL] [Abstract][Full Text] [Related]
16. Metabolic consequences of incorrect insulin administration techniques in aging subjects with diabetes.
Gentile S; Agrusta M; Guarino G; Carbone L; Cavallaro V; Carucci I; Strollo F
Acta Diabetol; 2011 Jun; 48(2):121-5. PubMed ID: 20091324
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of DSIP to normalize sleep in middle-aged and elderly chronic insomniacs.
Schneider-Helmert D
Eur Neurol; 1986; 25(6):448-53. PubMed ID: 3792404
[TBL] [Abstract][Full Text] [Related]
18. DSIP in sleep disturbances.
Schneider-Helmert D
Eur Neurol; 1986; 25 Suppl 2():154-7. PubMed ID: 3758119
[TBL] [Abstract][Full Text] [Related]
19. [The delta-sleep inducing peptide and its effect on the electroencephalogram and power spectrum density in rats with metaphit-induced epilepsy].
Stanojlovic O; Zivanovic D; Susic V
Srp Arh Celok Lek; 2001; 129(5-6):114-8. PubMed ID: 11797457
[TBL] [Abstract][Full Text] [Related]
20. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
